Motley Fool - 2025-07-06 10:47
Iovance Biotherapeutics has proven to be an innovative biotech. Over the past two years, Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has made significant clinical and regulatory progress. Penny stocks tend to be risky, but Iovance Biotherapeutics has an exciting approved product and several potential catalysts that could jolt its stock price.